About Kohjin Bio
Kohjin Bio is a company based in Sakado (Japan) founded in 1981. The company has 167 employees as of March 31, 2024. Kohjin Bio operates in a competitive market with competitors including Multus, Metatissue, Nu-Tek Biosciences, Sarvoshadhi Bio and metabolIQ, among others.
- Headquarter Sakado, Japan
- Employees 167 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Kohjin Bio Co.,Ltd.
-
Annual Revenue
$34.87 M (USD)9.14as on Mar 31, 2025
-
Net Profit
$5.32 M (USD)106.44as on Mar 31, 2025
-
EBITDA
$9.03 M (USD)50.83as on Mar 31, 2025
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
167
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Kohjin Bio
Kohjin Bio is a publicly listed company on the TSE with ticker symbol 177A in Japan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Kohjin Bio
Detailed funding history for Kohjin Bio
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Kohjin Bio
Investment portfolio details for Kohjin Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Kohjin Bio
Detailed financials for Kohjin Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Kohjin Bio Comparisons
Peer comparison for Kohjin Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Kohjin Bio
Kohjin Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Multus, Metatissue, Nu-Tek Biosciences, Sarvoshadhi Bio and metabolIQ, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of lab-grown meat alternatives
|
|
| Locked | Locked | Locked |
Provider of human protein-based products for cell culture, tissue engineering, and disease modeling applications
|
|
| Locked | Locked | Locked |
Develops innovative animal-free peptones and cell culture media for pharmaceutical use.
|
|
| Locked | Locked | Locked |
Customized cell culture media for biotechnology are developed.
|
|
| Locked | Locked | Locked |
Developer of cell culture medium for pharmaceutical screening and personalized medicine
|
Detailed competitors of Kohjin Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Kohjin Bio
Complete news archive for Kohjin Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kohjin Bio
Kohjin Bio was founded in 1981.
Kohjin Bio is headquartered in Sakado, Japan. It is registered at Sakado, Saitama, Japan.
Takato Nakamura is the current CEO of Kohjin Bio.
As of Mar 31, 2024, the latest employee count at Kohjin Bio is 167.
Annual revenue of Kohjin Bio is $34.87M as on Mar 31, 2025.
Kohjin Bio was founded in 1981 in Sakado, Japan, as a provider of tissue culture media. Focus is placed on developing serum-free media for research applications in regenerative medicine and immunotherapy. Operations center on the production and supply of these specialized media to support scientific investigations in the biotechnology sector. The companys activities are based in Japan, serving global research needs.
Kohjin Bio's top competitors include Multus, Onkologic and Cellular Engineering Technologies.
Yes, Kohjin Bio is publicly traded on TSE under the ticker symbol 177A.
The ticker symbol of Kohjin Bio is 177A on TSE.